Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Role of Obesity and Mediators of Adipose Tissue in Renal Transplant and Disease

Version 1 : Received: 29 December 2023 / Approved: 3 January 2024 / Online: 3 January 2024 (09:58:58 CET)

How to cite: Mota-Zamorano, S.; García-Pino, G.; Gervasini, G. Role of Obesity and Mediators of Adipose Tissue in Renal Transplant and Disease. Preprints 2024, 2024010238. https://doi.org/10.20944/preprints202401.0238.v1 Mota-Zamorano, S.; García-Pino, G.; Gervasini, G. Role of Obesity and Mediators of Adipose Tissue in Renal Transplant and Disease. Preprints 2024, 2024010238. https://doi.org/10.20944/preprints202401.0238.v1

Abstract

This review provides insight into the role that obesity, but especially mediators of the adipose tissue, have in both renal disease and transplantation. In particular, we focus on the functions of leptin and adiponectin, inflammatory mediators with widely known clinical implications, as well as on the role of arachidonic acid-derived eicosanoid metabolites. These latter compounds, epoxyeicosatrienoic (EETs) and hydroxyeicosatetraenoic (HETEs) acids, which modulate the liberation of cytokines in the adipose tissue, are generated in the epoxygenase pathway of arachidonic biotransformation via CYP450 enzymes. There is accumulating evidence suggesting that EETs and HETEs may have a critical role in the onset and outcome of chronic kidney disease and renal transplantation. Finally, we also discuss the reported effect that the presence of genetic variants in leptin, adiponectin, EETs and HETEs-related genes may cause in renal patients and recipients. The levels of cytokines of the adipose tissue and related compounds play a remarkable role in both renal disease and transplant. Accordingly, novel therapeutic strategies are being developed based on the modulation of their concentrations in patients with various diseases.

Keywords

chronic kidney disease; renal transplant; arachidonic acid; adipose tissue

Subject

Medicine and Pharmacology, Urology and Nephrology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.